Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ClearPoint Neuro Inc (CLPT) vs OneSpan Inc (OSPN) Price & Performance

ClearPoint Neuro IncTrade
OneSpan IncTrade

Price performance (Past 24H)

Key statistics

ClearPoint Neuro Inc vs OneSpan Inc — how do they compare? ClearPoint Neuro Inc trades at $14.75 (market cap $454.21M), while OneSpan Inc trades at $16.19 (market cap $600.69M). The key difference: OneSpan Inc is the larger of the two by market cap, and OneSpan Inc pays a 3.19% dividend while ClearPoint Neuro Inc pays none. Which is the better fit depends on your goals.

CLPTOSPN
Market Cap
$454.21M$600.69M
Sector
HealthTechnology
52-Week High
$29.60$16.78
52-Week Low
$8.66$10.15
Enterprise Value
$488.79M$569.77M
Dividend Yield
3.19%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ClearPoint Neuro Inc

ClearPoint Neuro (CLPT) trades at $14.56, down slightly by 0.07% today, with a bullish technical signal from moving averages but mixed oscillators. The company reported Q2 2026 revenue growth to $42 million but missed earnings estimates with a loss of $0.38 per share, reflecting ongoing investment in clinical and preclinical services. Despite negative net income margins and cash flow challenges, analyst consensus remains unanimously bullish with 3 buy ratings.

The outlook hinges on successful execution of growth initiatives in neuro drug delivery and regulatory progress with partners, though high valuation multiples and persistent losses pose significant risks. Near-term catalysts include Q3 2026 earnings and partner developments, but investors face volatility from operational cash burn and competitive pressures.

OneSpan Inc

OneSpan (OSPN) trades at $16.21, down 0.98% on the day, with strong technical momentum indicated by bullish moving averages. The company demonstrates robust fundamentals with a P/E of 9.21, net income margin of 27.76%, and consistent earnings beats in recent quarters. Recent Q2 2026 results showed revenue growth and raised full-year guidance, while the company continues paying $0.13 quarterly dividends.

Outlook remains positive with 67% analyst buy ratings and $17 consensus target offering 5% upside. Key risks include declining net cash flow and competitive pressures in the software sector. The stock presents value opportunity given attractive valuation multiples and strong profitability metrics, though investors should monitor execution against raised guidance.

Returns comparison

Trailing returns across standard periods

About ClearPoint Neuro Inc

ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.

Read more on CLPT

About OneSpan Inc

OneSpan Inc. is a global leader in providing digital agreement security solutions. The company's platform helps organizations, primarily in the financial services sector, to secure their digital agreements and transactions, including e-signatures, multi-factor authentication, and transaction monitoring. OneSpan's technology is focused on protecting customers from fraud and meeting regulatory compliance requirements in a digital-first environment.

Read more on OSPN